Healthcare Antitrust: New DOJ and FTC Merger Guidelines, Recent State Regulatory Changes
Recording of a 90-minute CLE video webinar with Q&A
This CLE course will guide healthcare counsel on recent antitrust developments and their implications for the healthcare industry. The panel will discuss the recent draft Merger Guidelines and state regulatory changes. The panel will also review recent Department of Justice (DOJ) and Federal Trade Commission (FTC) litigation and offer best practices for ensuring antitrust compliance.
Outline
- Federal guidance on mergers
- State regulatory changes
- DOJ and FTC litigation
- Implications of recent developments
- For healthcare antitrust
- For healthcare providers and other entities
- Best practices
Benefits
The panel will review these and other key issues:
- New draft Merger Guidelines issued by the DOJ and FTC
- Changes to healthcare antitrust enforcement at the state level
- Healthcare antitrust under the Biden administration
Faculty
Michael R. Greer
Shareholder
Hall Render Killian Heath & Lyman
Mr. Greer focuses his practice in the areas of antitrust law and managed care contracting. As part of his antitrust... | Read More
Mr. Greer focuses his practice in the areas of antitrust law and managed care contracting. As part of his antitrust practice, he has extensive experience in counseling health systems, hospitals and physicians on the antitrust requirements of mergers, acquisitions, joint ventures and provider networks. In this capacity, Mr. Greer frequently obtains clearance from the FTC and DOJ under the premerger reporting requirements of the Hart-Scott-Rodino (HSR) Act and defends providers in government antitrust investigations. During these government investigations, he manages complex procedural requirements, including large-scale document productions and electronic discovery and negotiates competition issues with the federal antitrust enforcement agencies. In addition, Mr. Greer routinely counsels healthcare providers on day-to-day antitrust compliance issues related to provider networks, managed care contracting, dominant firms and exchanges of competitively sensitive information, including “all or nothing” contracting, anti-tiering, anti-steering, gag clauses and price transparency. He also serves as part of an antitrust compliance monitoring team in monitoring antitrust agency consent orders.
Close
E. John Steren
Member
Epstein Becker & Green
Mr. Steren devotes a significant portion of his practice to helping healthcare organizations manage the antitrust risks... | Read More
Mr. Steren devotes a significant portion of his practice to helping healthcare organizations manage the antitrust risks of joint ventures and other business arrangements. He represents healthcare entities and providers in antitrust matters (counseling and litigation), including civil and government investigations and compliance with Hart-Scott-Rodino premerger notification requirements. He also focuses his practice on other complex commercial and civil litigation matters.
Close